Ensign Peak Advisors Portfolio holdings
AUM
$56.6B
1-Year Est. Return
28.41%
This Fund
S&P 500
1 Year Est. Return
+28.41%
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Holding
1,739
Top Buys
| 1 | +$201M | |
| 2 | +$135M | |
| 3 | +$123M | |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| 1 | +$267M | |
| 2 | +$183M | |
| 3 | +$172M | |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Natera
NTRA
$28.9B
| $35.1M | 0.06% |
153,326
-46,398
|
|
||
227
Air Products & Chemicals
APD
$60.8B
| $34.9M | 0.06% |
141,486
-55,649
|
|
||
|
MRSH
228
Marsh
MRSH
$89.2B
| $34.9M | 0.06% |
188,090
+49,784
|
|
||
229
Waters Corp
WAT
$30.6B
| $34.8M | 0.06% |
91,740
-16,342
|
|
||
230
IDEAYA Biosciences
IDYA
$3.01B
| $33.8M | 0.06% |
979,063
+225,899
|
|
||
231
Freeport-McMoran
FCX
$94.2B
| $33.7M | 0.06% |
663,796
-307,806
|
|
||
232
Idexx Laboratories
IDXX
$50.7B
| $33.6M | 0.06% |
49,695
+4,365
|
|
||
233
Syndax Pharmaceuticals
SNDX
$1.86B
| $33.6M | 0.06% |
1,598,544
+789,480
|
|
||
234
Synopsys
SNPS
$81.2B
| $33.6M | 0.06% |
71,451
+5,082
|
|
||
235
Cardinal Health
CAH
$53.3B
| $32.8M | 0.06% |
159,558
-96,528
|
|
||
236
Howmet Aerospace
HWM
$104B
| $32.6M | 0.06% |
158,993
-5,108
|
|
||
237
Newmont
NEM
$129B
| $32.3M | 0.06% |
323,708
+50,301
|
|
||
238
Equitable Holdings
EQH
$11.1B
| $31M | 0.05% |
651,388
-360,633
|
|
||
239
Eaton
ETN
$138B
| $31M | 0.05% |
97,307
-7,997
|
|
||
240
Travere Therapeutics
TVTX
$2.53B
| $30.8M | 0.05% |
805,215
-46,987
|
|
||
241
Royalty Pharma
RPRX
$20.3B
| $30.5M | 0.05% |
790,302
-16,550
|
|
||
|
FISV
242
Fiserv Inc
FISV
$33.8B
| $30.5M | 0.05% |
453,491
-29,153
|
|
||
243
Doximity
DOCS
$4.98B
| $30.3M | 0.05% |
684,621
-55,809
|
|
||
244
MetLife
MET
$47.6B
| $30.2M | 0.05% |
383,202
-133,156
|
|
||
245
Madrigal Pharmaceuticals
MDGL
$9.67B
| $29.7M | 0.05% |
51,010
-2,257
|
|
||
246
Hartford Financial Services
HIG
$39.1B
| $29.7M | 0.05% |
215,423
-49,966
|
|
||
247
Equinix
EQIX
$95.5B
| $29.5M | 0.05% |
38,518
-24,767
|
|
||
248
WESCO International
WCC
$14B
| $29.3M | 0.05% |
119,800
-31,855
|
|
||
249
iShares MSCI ACWI ex US ETF
ACWX
$9.03B
| $29.3M | 0.05% |
436,044
+64,513
|
|
||
250
Fortive
FTV
$18.2B
| $29.2M | 0.05% |
528,339
-101,082
|
|